Key Facts and Data Points

  • Peptides: Short chains of 2‑50 amino acids; smaller than proteins (≥50 aa).\
  • Biological Role: Act as hormones, neurotransmitters, and local regulators influencing metabolism, immunity, and tissue repair.\
  • Therapeutic Mechanism: Bind to specific cell‑surface receptors (lock‑and‑key) to trigger targeted responses with comparatively fewer side effects.\
  • Administration: Primarily sub‑cutaneous injections; oral route limited due to enzymatic degradation.\
  • Major Clinical Applications:\
  • Diabetes & Obesity: GLP‑1 analogues (e.g., liraglutide, semaglutide).\
  • Oncology: Peptide‑drug conjugates targeting tumour receptors.\
  • Regenerative Medicine: Muscle, nerve, tendon repair peptides.\
  • Dermatology, Wound Healing, Osteoporosis, Cardiovascular, Viral infections.\
  • Safety Concerns: Unapproved “research chemicals” sold online lead to endocrine imbalance, metabolic disturbances, and cardiovascular risks.

Background and Context

Peptide therapeutics bridge the gap between small‑molecule drugs and biologics. Their specificity and biodegradability make them attractive, especially for chronic diseases where long‑term safety is paramount. The surge in bio‑hacking culture has, however, created a parallel market of unregulated peptide products.

Significance for India / Governance / Policy

  • Healthcare Innovation: Adoption can reduce disease burden (diabetes prevalence ~77 million).\
  • Regulatory Framework: Need for stringent approval pathways under CDSCO, akin to biologics.\
  • Public Health Safety: Awareness campaigns to curb self‑injection of untested peptides.\
  • Research & Development: Incentivising domestic peptide drug discovery aligns with ‘Make in India’ for biotech.

Related Constitutional / Legal Provisions

  • Article 21 – Right to health; state duty to ensure safe medical products.\
  • Drugs and Cosmetics Act, 1940 – Governs approval, manufacturing, and sale of peptide therapeutics.\
  • National Pharmaceutical Pricing Authority (NPPA) – May regulate pricing of high‑cost peptide drugs.

References

  • Bioactive Peptides (link provided in article)